financetom
Business
financetom
/
Business
/
Colgate-Palmolive raises 2024 forecasts on strong demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Colgate-Palmolive raises 2024 forecasts on strong demand
Jul 26, 2024 5:42 AM

July 26 (Reuters) - Toothpaste maker Colgate-Palmolive ( CL )

raised its forecasts for annual profit and organic sales

on Friday, after beating second-quarter estimates on resilient

demand for its high-priced products.

WHY IT'S IMPORTANT

Organic sales in the Latin American segment - a major

revenue-generating region - jumped 18.8% in the quarter,

compared with a 16% rise a year earlier.

Increased investments in advertising also helped the company

counter rising competition from lower-priced private labels.

CONTEXT

Consumer packaged goods companies such as Colgate-Palmolive ( CL )

and Kimberly-Clark ( KMB ) have reported a rise in sales volumes

on steady demand, despite consecutive price hikes.

Higher product prices also helped Colgate-Palmolive ( CL ) counter

rising raw materials and packaging costs, expanding its gross

profit margins by 280 basis points to 60.6% during the quarter.

KEY QUOTE

"The strong levels of investment should continue in the

balance of the year as we focus on building brand health and

scaling the capabilities needed to drive growth in both the

short and long term," said CEO Noel Wallace.

BY THE NUMBERS

Colgate-Palmolive ( CL ) expects annual profit growth between 8%

and 11%, compared with its prior forecast of mid- to

high-single-digits.

Full-year organic sales growth was projected to be between

6% and 8%, up from its previous expectations of 5% to 7%.

Colgate-Palmolive's ( CL ) product prices rose 4.2% in the second

quarter. Its organic volumes jumped 4.7%, after having dipped 3%

in the year-ago quarter.

The company posted a quarterly adjusted profit of 91 cents

per share, compared with analysts' average estimate of 87 cents,

according to LSEG data.

The company's net sales of $5.06 billion beat estimate of

$5.01 billion.

MARKET REACTION

Shares of the company rose about 1% in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MediaAlpha Closes $144.2 Million Secondary Offering
MediaAlpha Closes $144.2 Million Secondary Offering
May 10, 2024
09:30 AM EDT, 05/10/2024 (MT Newswires) -- MediaAlpha ( MAX ) announced Friday the closing of a secondary offering of nearly 7.6 million class A common shares previously owned by affiliates of White Mountains Insurance Group ( WTM ) and Insignia Capital Group at $19 apiece, generating $144.2 million in gross proceeds for the selling shareholders. Underwriters for the deal...
Home Depot Likely to Post 'Largely in Line' Q1 Results, Reiterate Outlook, Wedbush Says
Home Depot Likely to Post 'Largely in Line' Q1 Results, Reiterate Outlook, Wedbush Says
May 10, 2024
09:41 AM EDT, 05/10/2024 (MT Newswires) -- Home Depot's ( HD ) Q1 results on May 14 will likely be largely in line with market expectations and the retailer will likely also reaffirm its conservative 2024 guidance, Wedbush said in a note to clients on Friday. While we initially viewed the company's 2024 guidance as conservative, we now see it...
Factbox-Chinese EV makers set sights on European production
Factbox-Chinese EV makers set sights on European production
May 10, 2024
(Reuters) -Some Chinese carmakers are looking to set up manufacturing and assembly plants in Europe as they aim to ramp up sales of lower-cost cars in the region to rival their European competitors amid slowing demand at home. European imports of Chinese-made electric vehicles (EVs) have soared in recent years, raising concerns among domestic EV producers that they could suffer...
iTeos Therapeutics Q1 Net Loss Widens; Initiates $120 Million Registered Direct Offering -- Shares Jump
iTeos Therapeutics Q1 Net Loss Widens; Initiates $120 Million Registered Direct Offering -- Shares Jump
May 10, 2024
09:40 AM EDT, 05/10/2024 (MT Newswires) -- iTeos Therapeutics ( ITOS ) reported a Q1 net loss Friday of $1.07 per diluted share, widening from a net loss of $0.44 per share a year earlier. Four analysts polled by Capital IQ expected a loss of $1.37. The clinical-stage company said it ended Q1 with $595 million in cash, cash equivalents,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved